Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-11-21

FDA Approved: IMVEXXY — Supplemental Application (Mayne Pharma LLC)

View source ↗

Summary

The FDA approved a supplemental application for IMVEXXY (estradiol) submitted by Mayne Pharma LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • IMVEXXY (Estradiol)

Snippet

SUPPL AP for IMVEXXY (ESTRADIOL)